News : 2016 : December

RECENT EVENTS JANUARY 2017

Since the beginning of the AIDS epidemic, the University of Miami has been at the forefront of the effort to prevent, treat and find a cure for HIV/AIDS. Work on new approaches to prevent and cure HIV infection is currently underway at UM’s Medical School and with their colleagues around the country. We recently held two events with two of the world’s leading pioneers of this work as our guest speakers.

Wednesday, Jan 18: Meet the Luminaries – Quest for a Cure

The University of Miami Institute of AIDS & Emerging Infectious Diseases (PBIDI) and SAVE, South Florida’s leading LGBTQ advocacy organization, hosted Raymond F. Schinazi, Ph.D., D.Sc., and Robert C. Gallo M.D., on Wednesday, January 18, 2017 from 6 p.m. to 8 p.m. (EST) at the Life Science Technology Park Lobby, 1951 NW 7th Ave, Miami, FL 33136. Refreshments, hors d’oeuvres, PrEP informational pamphlets and lab tours were provided. We also had a few University of Miami physicians talking about exciting programs such as PrEP, Needle Exchange and Rapid Response. We had an amazing event and thank all who attended.

Thursday, Jan 19: An Evening with HIV/AIDS Pioneers

On Thursday, January 19, 2017 from 6 p.m. to 8 p.m. (EST) at the Stonewall National Museum – Wilton Manors Gallery, 2157 Wilton Dr, Wilton Manors 33305, Drs. Schinazi and Gallo spoke to the attendees in an intimate setting within the gallery and had a very engaging question and answer period after the talks. The evening was inspiring and educational and we appreciate all who attended. The goal of the University of Miami Institute of AIDS & Emerging Infectious Diseases (PBIDI) is to transform and limit the AIDS epidemic in South Florida and beyond through innovative and cross-disciplinary research. Hors d’oeuvres, refreshments and HIV and Florida informational handouts were provided.

About the Featured Speakers:

Raymond F. Schinazi, Ph.D., D.Sc.
Dr. Schinzi is best known for his pioneering work on HIV, HBV, HCV drugs d4T(stavudine), #TC(lamivudine), FTC (emtricitabine), LdT(telbivudine), and sofosbuvir (Sovaldi), ehich are all approved by the U.S. FDA. More then 94% of HIV-infected individuals in the United States are on combination with the drugs he invented. He is Professor of Pediatrics and Director of the Laboratory of Biochemical Pharmacology at Emory University.

Robert C. Gallo M.D.
Dr. Gallo is a two-time Lasker prize winner and NaDonal Academy member, best known for co-discovering HIV as the cause of AIDS in 1984. Little was known then of the mysterious disease that was fast becoming the deadliest in medical history. Gallo and his team pioneered the development of the HIV blood test, which enabled health care workers for the first time to screen for the AIDS virus – leading to a more rapid diagnosis while simultaneously protecting patients receiving blood transfusions. He is co-founder and current Director of the Institute of Human Virology at the University of Maryland School of Medicine.

Mario Stevenson, Ph.D
Dr. Stevenson is currently Professor in the Department of Medicine, Chief of the Division of Infectious Diseases, Director of the University of Miami Institute for AIDS & Emerging Infectious Diseases and Co-Director of the Miami Center for AIDS Research. Dr. Stevenson’s research focuses on mechanisms of viral persistence and immunopathogenicity.